Friday, December 8, 2023
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

admin - 0
Latest Pharma-News

Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi

admin - 0
Latest Pharma-News

FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI

admin - 0
Latest Pharma-News

Sandoz receives approval by EC for Hyrimoz® high-concentration formulation

admin - 0
Latest Pharma-News

AZ’s Lynparza and Imfinzi combination shows positive results in advanced ovarian cancer

admin - 0
Latest Pharma-News

FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings

admin - 0
Latest Pharma-News

Ultomiris recommended for approval in EU for neuromyelitis optica spectrum disorder

admin - 0
Latest Pharma-News

FDA Approves First Over-the-Counter Naloxone Nasal Spray

admin - 0
Latest Pharma-News

License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed

admin - 0
Latest Pharma-News

IOnctura Awarded UK’s MHRA Innovation Passport For Entry ILAP

admin - 0
Latest Pharma-News

EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy

admin - 0
Latest Pharma-News

BMS Sotyktu approves for the Treatment of Moderate-to-Severe Plaque Psoriasis

admin - 0
123...144Page 2 of 144
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved